Key points are not available for this paper at this time.
Genetic deletion of PKM2 in myeloid cells or limiting its nuclear translocation reduces atherosclerosis by suppressing inflammation and enhancing efferocytosis.
Doddapattar et al. (Mon,) studied this question.